New-onset atrial fibrillation after percutaneous coronary intervention or coronary artery bypass grafting for left main disease

Harun Avdagić; Ivana Iveljić; Elmir Jahić; Selma Sijerčić; Alisa Krdžalić; Amar Skakić; Jasenko Radović; Emir Ahmetašević

doi:10.17392/1014-19

Review paper

Received: 15.02.2019. >> Accepted: 29.03.2019. >> Published: 10.05.2019. Biochemistry

<< Prev | Next >>

PDF

https://doi.org/10.17392/1014-19

New-onset atrial fibrillation after percutaneous coronary intervention or coronary artery bypass grafting for left main disease

Abstract

Aim
To determine the prevalence of new-onset atrial fibrillation (NOAF) following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for left main coronary artery disease (LMCAD) and its effect on 6-month cardiovascular outcomes.
Methods
This prospective study included 40 patients diagnosed with LMCAD, in the period from 2017 to 2018. The patients with LMCAD and low or intermediate SYNTAX score were randomized to PCI with zotarolimus-eluting stents versus CABG. Outcomes were analyzed according to the development of NOAF during the initial hospitalization following revascularization. Results
Among 40 patients without atrial fibrillation on presentation, NOAF developed 3.1±1.3 days during hospitalization in three CABG treated patients, and one PCI treated patient. One patient that was CABG treated developed NOAF after two months. Patients with versus patients without NOAF had a significantly longer duration of hospitalization, probably because they were discharged on anticoagulant therapy. Myocardial infarction was presented in one CABG treated patient after 3 months, and also in one PCI treated patient after 4 months. One patient died 2 months after the operation, and one developed stroke 5 months after the CABG operation.
Conclusion
The NOAF was common after CABG, but extremely rare after PCI, and it occurred almost exclusively following CABG. There was a clear statistical tendency for all-cause death, cardiovascular death and stroke at 6-month follow-up period.

Keywords:

atrial fibrillation,

coronary artery disease,

coronary bypass surgery,

percutaneous coronary intervention,

prognosis

References

Chelazzi C, Villa G, Gaudio D, A. Postoperative Atrial Fibrillation ISRN Cardiol 2011:203179.

Reiffel J, Verma A, Kowey P, Halperin J, Gersh B, Wachter R, et al. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study. JAMA Cardiol 2017:1120–7.

Melduni R, Schaff H, Bailey K, Cha S, Ammash N, Seward J, et al. Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study. Am Heart J 2015:659–68.

Horwich P, Buth K, Legare J. New onset postoperative atrial fibrillation is associated with a longterm risk for stroke and death following cardiac surgery. J Card Surg 2013:8–13.

Palmerini T, Biondi-Zoccai G, Reggiani L, Sangiorgi D, Alessi L, Servi D, et al. Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. J Am Coll Cardiol 2012:798–805.

Capodanno D, Stone G, Morice M, Bass T, Tamburino C. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011:1426–32.

Kuss O, Salviati V, Borgermann B, J. Off pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses. J Thorac Cardiovasc Surg 2010:829–35.

Almassi G, Pecsi S, Collins J, Shroyer A, Zenati M, Grover F. Predictors and impact of postoperative atrial fibrillation on patients’ outcomes: a report from the Randomized On Versus Off Bypass trial. J Thorac Cardiovasc Surg 2012:93–102.

Ommen S, Odell J, Stanton M. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997:1429–34.

Antonic M, Lipovec R, Gregorcic F, Juric P, Kosir G. Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients. J Cardiol 2017:98–102.

Kaw R, Hernandez A, Masood I, Gillinov A, Saliba W, Blackstone E. Short-and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2011:1305–12.

Echahidi N, Pibarot P, Hara O, Mathieu G, P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008:793–801.

Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2018:87–165.

Arom K, Emery R, Petersen R, Bero J. Evaluation of 7,000 patients with two different routes of cardioplegia. Ann Thorac Surg 1997:1619–24.

Head S, Farooq V, Serruys P, Kappetein A. The SYNTAX score and its clinical implications. Heart 2014:169–77.

Makaikallio T, Holm N, Lindsay M, Spence M, Erglis A, Menown I, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE ): a prospective, randomised. Lancet 2016:2743–52.

Stone G, Sabik J, Serruyus P, Simonton C, Genereux P, Puskas J, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016:2223–35.

Sy M, Park D, Yun S, Kim Y, Lee J, Kang S, et al. Major predictors of long-term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: analysis from the MAIN-COMPARE study. Circ Cardiovasc Interv 2010:127–33.

Knotzer H, Dunser M, Mayr A, Hasibeder W. Postbypass arrhythmias: patopshyhology, prevention, and therapy. Curr Opin Crit Care 2004:330–5.